A Message From 23andMe CEO Anne Wojcicki

Anne Wojcicki
1 follower
1 Video View·Apr 15, 2026
23andMe has had a lot of ups and downs over the past few years, but now that Anne Wojcicki has been back at the head of the company after the recent bankruptcy, Anne Wojcicki has sent out a message to the 23andMe community. In this video, I'm going to read through the message from Anne Wojcicki and give my opinion on it.
Hello everybody, I am Jarrett Ross, the Genie Vlogger, and on today's video we are going
to be discussing 23andMe.
The main thing that I'm kind of basing this video around is a recent message sent to the
23andMe community from their founder and CEO, Ann Wojcicki.
I imagine most people watching this are already quite familiar with a lot of the issues 23andMe
has had over the past few years, along with some general issues going on in the genetic
genealogy community and DNA testing because of issues around investigative genetic genealogy.
And I know that's kind of a lot just within that one sentence, but to start, the issues
that have happened over the past few years include what's known as a credential stuffing
attack, which is kind of a form of hacking where people take a database of known emails
and passwords and then go onto a single website and try all those emails and passwords.
So someone did that to 23andMe, they were able to log into a bunch of different accounts
and thus obtain the personal information listed in those accounts.
And then along with that, 23andMe has been having serious issues as just a company staying
afloat.
I think a big part of that really being that their business model for a long time has been
about medical testing and scientific testing and basically getting a bunch of users to
do the 23andMe test so that they can then use that in further studies.
23andMe has had an opt-in, opt-out system for research studies, so you can choose if
your DNA is included in that if you do a test.
But because of the financial issues 23andMe was having, they had to declare bankruptcy
and then there was a potential that they would be sold.
So a lot of people jumped ship from 23andMe in the worries that the database would be
sold and then their user data would then be under new rules which might allow it to be
used and given away without their permission.
On top of all of those issues, the DNA testing community and genetic genealogy has had some
serious issues because of people jumping ship due to investigative genetic genealogy.
So this is the use by law enforcement of these databases to identify unknown human remains
as well as identify violent perpetrators of cold case crimes.
Now not all of the databases were part of this and in fact 23andMe did not allow law
enforcement to use their database nor did they even have a way for law enforcement to
nefariously do that because 23andMe does not have a way to upload or transfer DNA into
their database.
But that didn't really matter, people were still going to jump ship especially because
a lot of the reporting around it was really bad and there were just a lot of videos of
people just jumping on the fear mongering ship and just being like, delete it, delete
it, delete it.
And tons of people deleted their 23andMe kits, didn't think that much about it.
Some obviously did and you know, people have their choice if they want to keep it there
or not.
But I have personally heard from people who were actually upset later that they did delete
their kits because they didn't really realize the risks, they thought the risks were worse
than they were because there are risks, there's no denying that.
Anyone that says there are no risks to DNA testing, they're obviously lying.
But even so, considering the risks, if you're made to believe the risks are much worse,
being told that your DNA is going to be used for cloning and for faking crimes and doing
all these things that you can't really do, people thought that some of this stuff was
real.
There was even a video on Facebook from some content creator couple that I did a comment
on, which is not something I commonly do, but I just felt like I needed to say something
because their video just was so beyond reality.
And they actually ended up responding to me and at first I think they were kind of dismissive
until they realized that I actually have some backing to my knowledge.
I actually have experience as an investigative genetic genealogist and I actually know what
I was talking about, which funny enough, one of the things they said in response to me
was that, you know, oh, well I'm a lawyer, I should know.
And as an investigative genetic genealogist who has worked with many lawyers and many
law enforcement officers, I can tell you the lack of knowledge amongst that group is very
great because they don't deal with genetic genealogy, they know little bits and pieces
of stuff.
But honestly, I'm getting off topic.
So the main thing being is that a lot of people jumped ship from 23andMe for all of these
different things that were going on.
Now one other thing I do want to mention as well before we get into the message from Ann
Wojcicki is that the genetic genealogy community for some time now has been moving slowly away
from 23andMe.
For a long time, 23andMe was like the place that genetic genealogists suggested people
tested at.
And after a couple of different things where 23andMe basically kind of turned their back
on the genetic genealogy community and started to take things away from their database that
helped genetic genealogy, basically making it less useful, it kept pushing genealogists
further and further away.
And only in the past year or two has that started to turn around with 23andMe releasing
updates to the ad mixture, updates to the database, updates to their premium subscription,
which is something that I think they're using to try to create a new business model because
the selling data to medical companies and things like that didn't seem to really be
working out.
So over the past year, it seems in my opinion that 23andMe has been starting to steer the
ship in the right way.
So there was going to be a sale of the company to this other company called Regeneron.
And then Ann Wojcicki came in with some nonprofit that she used to then buy the company back.
And so now she's back at the helm, which I believe that happened back in like July or
something of this year.
So you know, she's been at it for about four or five months.
So now with all that said, let's jump into the actual statement that Ann Wojcicki sent
out to the 23andMe community.
As we close out 2025, I want to thank all of you for being part of the 23andMe community
and tell you why I'm so excited about the future ahead.
2025 was an eventful year that challenged 23andMe, our policies and the strength of
our community.
I'm happy to be on the other side of it all and grateful to be focused on the opportunities
ahead.
23andMe has always been more than just a company to me.
It's been a movement to elevate the voice of all of you to say we want to have rights
to our own data and have a greater say in our health.
Evolving into a nonprofit this year gave us the opportunity to solidify our mission and
promise that our first priority will always be you, our members, and the impact we can
collectively have.
2026 will mark 20 years since the start of 23andMe, and I have been thinking a lot about
what the next decade of genetics, personalized healthcare, and the intersection of AI and
research discoveries mean for all of us, and it's exciting.
So at this point, one of the first things I want to point out, and other genealogists
may have noticed this, is that nothing has been said about the genealogy or family history
side of things.
And honestly, this has kind of been a thing that I think has been an issue with 23andMe
is that they don't recognize that the genealogy side of the business is where they can make
a serious continual revenue flow.
And it seems like Ann Wojcicki is still in the mindset she had before the bankruptcy.
So to me, it kind of worries me that some of these things that we've seen them put out
over the past year that have helped in the genealogy community, that we're not going
to really see much more of that, and possibly it's just going to revert back to where we
may lose more things.
And I remember a lot of other genealogists actually saying something along these lines
when it happened that the non-profit Ann Wojcicki had created was able to actually buy 23andMe
back.
Basically, they were worried that, okay, well, she's back at the helm, she's just going
to do what she did previously.
And then the genealogy community won't want to be a part of it.
23andMe recently became a non-profit medical research organization dedicated to accelerating
our mission, enabling each and every person to benefit from personalized health care and
to dramatically accelerate scientific discoveries so we can all live longer, healthier lives.
As a non-profit, we can fully focus on impact using science and collaboration to benefit
human health.
This new structure empowers all of us to get the goal of living healthier lives as quickly
as possible.
To get there, we'll be deepening our collaborations with universities, non-profits, government,
and industry so that breakthroughs can happen faster, bringing the benefits to reach more
people in more places more equitably.
Once again, it's not a single mention of anything genealogy or family history-wise,
100% medical.
And, you know, if that's the way that they want to go, that's the way that they want
to go.
But I think that, number one, it's a bad business decision because it's already been
shown that they can't stay afloat that way.
I mean, I imagine now that they are a non-profit, that's going to change things slightly in
how they, you know, can handle things and, you know, whatever.
But I think that it's just rehashing the same thing.
And then the other piece being that, from my own experience, it seems that the large
majority of people that are on 23andMe were testing because of the genealogy things much
more than the health side of things.
But no matter what, even if they were testing for the health side of things, there's so
many people that aren't going to be comfortable with their data then being used to be sold
and all that, so they're not going to opt in for their data to be included in that.
Not even mentioning that that's going to make a bunch of people not want to test in
23andMe because, one, people aren't going to know there's an opt-in, opt-out thing,
so they're just going to assume their data is going to be sold.
And number two, if they think that is the main part of the business model, then if it
ever does get sold, they're worried that their data will be used for that, just like
we saw a whole bunch of people jumping ship.
But now we're going to look at this section, the future ahead for 23andMe members, so
cross our fingers and hope maybe there's something.
More reports and features for you!
As our research expands, you'll continue to receive more detailed health and ancestry
updates.
Our community of over 13 million members powers some incredible genetic research, from
cancer research to new ancestry discoveries.
Since August, we've introduced new 23andMe Plus member reports on ACL tears, endometriosis,
gastroesophageal reflux disease, and white blood cell count.
We also released our biggest Ancestry composition update ever, adding extensive new regions
to better reconnect the African diaspora, and offering the most granular, comprehensive
genetic breakdown on the market of 4,500 plus regions.
So here's really the only place that Ancestry is mentioned, and it's not even what you
have to look forward to, it's what we've already done.
And so that's something that kind of leads into the worrying more about, well, are they
going to improve anything that they have, or they just kind of figure, let's do some
stuff, we got to get something to get the genealogy community back on there.
Now, the thing that they did most recently that was like the biggest jump I've seen of
genealogists, like, okay, I'm going to spend money at 23andMe, was when they released their
Reconstructed Genomes feature, which is a feature that allows you to take the DNA from
your shared relatives that you know how you're related, and then reconstruct the genomes
of your ancestors.
So basically, you know your DNA comes from this cousin, and they're on your paternal
side, well, that shared DNA must be from your father, so we can then put that to your father,
and now we've got part of his DNA reconstructed.
So this was something behind their 23andMe Plus membership, and that got me to pay for
it, number one, because it was something I really wanted to talk about in a video, and
I think I talked about it in a video, maybe a live, and then it got a bunch of other people
wanting to play around with it.
Now, in all honesty, after I played around with it, it was not that great of a tool,
it was interesting, but the main thing with it was that there was a lot of potential for
the future if they made those reconstructed profiles available to compare against their
database, because if you have a reconstructed profile for your grandparents, and you can
compare that in the database, you're going to get some better matching than comparing
your own profile.
AI and health.
AI is already transforming how we're thinking about healthcare for all of us.
23andMe recently launched an AI-powered version of our health action plan feature, only available
to 23andMe Plus members in the United States, and is vesting in better ways to summarize
and prioritize your results so you can be the best advocate for your own healthcare.
AI is also having a significant impact on research.
Just this month, we released the only genetic papers at the AI conference, NOR-IPS, demonstrating
what is possible with using DNA to predict disease risk, and then a link to the article
that they talked about.
Research fuels more discovery, your participation in research makes an impact, answering one
question has a multiplier effect, and empowers research in multiple areas.
We want to make a difference in areas that matter to you, your family, and your community.
Answering surveys and linking to Apple Health has helped us generate over 300 peer-reviewed
papers.
Our recent collaborations have revealed new genetic insights into dyslexia, depression,
and stuttering.
We're also actively recruiting participants for our lung cancer research platform and
Parkinson's community to help scientists develop new treatments and a cure.
With a growing community of over 13 million people, we have the ability to have an even
greater impact in the years ahead.
So much better to actually just use an actual geneticist.
But the main thing kind of goes back again to, well, if you want to do all these things
and do them as best possible, you need more people to test.
What's going to be the actual thing that's going to get the most people to test is genetic
genealogy, the family history side of things.
That's going to really help build a lot of what they're trying to do on the medical
side, because like I said, I think it's going to get the most people to test.
A leadership team and structure to support you and your choices.
Respecting your choice and being transparent will always be core driving principles at
23andMe.
We believe in empowering you with critical information and always want to give you choice
about how your data are or are not used.
Too often in healthcare, people feel out of control, and we want to lead by example by
always putting you first.
This year, we strengthen our governance by expanding our board of directors and establishing
a new privacy advisory board to ensure we keep your data secure and maintain your trust.
We continue to work with an independent external institutional review board, an ethics review
committee on all of our research, and we've added new leadership roles to build our philanthropy
and nonprofit strategy moving forward.
Now this paragraph is honestly interesting to me because one of the big news pieces that
a lot of you may have remembered from like a year or so ago, I can't remember if it
was before or during the bankruptcy, was that the entire board of directors quit.
And I believe that they basically quit on Ann Wojcicki.
And I know when I saw that, that was something I was like wondering, like, huh, I wonder
if, you know, maybe they all quit because they all were like, we need to do something
about the genetic genealogy side, the family history side, we need to improve it.
We need this to be a viable business.
We need the revenue flow to actually make sense.
And having it where the revenue flow is people paying for DNA kits and then medical research
companies paying for access to the database, it's not as viable, I guess, as they thought
it would be.
Otherwise, I doubt they would have been filing Chapter 11 bankruptcy.
So I am also curious with what they said here, you know, are some of these board of directors
the same ones from before or is it a new one or what?
I haven't really looked into this enough to know and I wouldn't even know if I saw some
of the same people were coming back what that would necessarily mean.
But interesting nonetheless.
So let's continue.
So 2026 and beyond.
As we look forward almost 20 years since 23andMe launched, I thank you again for being a part
of the community.
The next decade of genetics, personalized health care and research discoveries is full
of potential.
Together, we can improve lives today and leave a lasting impact for generations to come.
With gratitude, Ann Wojcicki, founder and CEO, 23andMe Research Institute.
So that's the message.
I definitely don't feel super confident with that message.
I know I'm kind of rehashing what I've said already, but it really does feel like it's
just going to be business as normal from before everything happened and they're not going
to try to do anything to improve the genetic genealogy side and that's what they really
need to do.
Now, I am definitely biased as a genetic genealogist because that's what I want 23andMe for.
I, you know, I understand the lack of usefulness of consumer DNA tests for medical testing.
Also, considering that 23andMe doesn't do a whole genome sequencing, meaning that they're
only testing a small percentage of your entire genome, that means that there's a lot that
they're missing out on.
And I know this is one of the things that MyHeritage is going to be doing.
They're going to be changing all of their testing to whole genome sequencing.
Even so, there are whole genome sequencing companies out there like Nebula and Dante,
which do have advanced medical study comparisons.
So you can look at a medical study and see in depth what variations are matching or aren't
matching and basically, you know, how many of all of the variants do you have?
Whereas with 23andMe, they're only looking at a few of the variants in each one of the
things that they're testing for.
It's like one of the ones I remember the numbering for, and I don't know if it's still the case,
but I remember it used to be the case at the very least, was that for breast cancer, 23andMe
was only utilizing three variants to say, do you have a high risk or not?
But when it comes to breast cancer, it's actually over a thousand variants that are part of
figuring that out.
So three variants out of the total 1,000 kind of goes to show you how minimal the information
you can get from 23andMe is for medical testing.
I think the real medical benefit from 23andMe isn't personalized health care for each tester
necessarily.
I think it's more of a societal benefit in that they have a large database to now utilize
for better genetic testing.
Granted, it's still limited to the about 1% of your total DNA that they're testing.
They're testing about 700,000 different variants in your DNA, different spots in your DNA.
Yet you have over 2 billion spots in your DNA.
Now I could be wrong and it might just be that because this is a message from Ann Wojcicki,
it is so much heavily leaning towards the medical things and not the genetic genealogy
things.
And they do have stuff in the pipeline on things that are trying to improve.
And I definitely hope that's the case.
If you enjoyed this video and you want to see other videos just like it, be sure to
check out this one of mine right here.
Thank you to my Patreon patrons and YouTube members.
